Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis

NCT02737202 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02737202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02737202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2016
Completion date
July 30, 2019
Enrollment
28 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary lymphangioleiomyomatosis